MS4A4A Gene — Membrane-Spanning 4-Domains A4A

MS4A4A Gene — Membrane-Spanning 4-Domains A4A

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MS4A4A Gene — Membrane-Spanning 4-Domains A4A</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MS4A4A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Membrane-Spanning 4-Domains A4A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11q12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>246213</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>614508</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000166926</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H3Y1</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>199 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~22 kDa</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">rs15805 (T allele)</td>
<td>Protective</td>
</tr>
<tr>
<td class="label">rs6102059</td>
<td>Risk</td>
</tr>
<tr>
<td class="label">rs6859</td>
<td>Protective</td>
</tr>
<tr>
<td class="label">rs676309</td>
<td>Risk</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CD36</td>
<td>Co-localization</td>
</tr>
<tr>
<td class="label">TLRs

MS4A4A Gene — Membrane-Spanning 4-Domains A4A

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MS4A4A Gene — Membrane-Spanning 4-Domains A4A</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MS4A4A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Membrane-Spanning 4-Domains A4A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11q12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>246213</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>614508</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000166926</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H3Y1</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>199 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~22 kDa</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">rs15805 (T allele)</td>
<td>Protective</td>
</tr>
<tr>
<td class="label">rs6102059</td>
<td>Risk</td>
</tr>
<tr>
<td class="label">rs6859</td>
<td>Protective</td>
</tr>
<tr>
<td class="label">rs676309</td>
<td>Risk</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CD36</td>
<td>Co-localization</td>
</tr>
<tr>
<td class="label">TLRs</td>
<td>Signaling cooperation</td>
</tr>
<tr>
<td class="label">Lipid rafts</td>
<td>Membrane microdomain</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">White matter</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Physical interaction</td>
</tr>
<tr>
<td class="label">CD33</td>
<td>Related family</td>
</tr>
<tr>
<td class="label">PLD3</td>
<td>Microglial pathway</td>
</tr>
<tr>
<td class="label">ABI3</td>
<td>Wiskott-Aldrich pathway</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">MS4A4A</td>
<td>Microglia</td>
</tr>
<tr>
<td class="label">MS4A6A</td>
<td>Microglia</td>
</tr>
<tr>
<td class="label">MS4A1</td>
<td>B cells</td>
</tr>
<tr>
<td class="label">MS4A2</td>
<td>Mast cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">TUMOR</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

MS4A4A (Membrane-Spanning 4-Domains A4A) is a member of the MS4A (Membrane-Spanning 4-Domains subfamily A) gene family that encodes a membrane protein expressed primarily in immune cells, particularly [microglia](/cell-types/microglia-neuroinflammation) and other myeloid cells. Genetic variants in MS4A4A have been identified as significant risk factors for [Alzheimer's disease](/diseases/alzheimers-disease) through genome-wide association studies (GWAS), positioning this gene at the intersection of neuroinflammation, lipid metabolism, and neurodegeneration. [@sims2017]

Overview

The MS4A gene family consists of at least 12 genes (MS4A1-MS4A12) located in a tight cluster on chromosome 11q12. MS4A4A encodes a tetraspanin-like membrane protein that functions as a calcium channel or signaling molecule. The gene has emerged as an important [Alzheimer's disease](/diseases/alzheimers-disease) risk gene, with protective variants associated with reduced disease risk and altered microglial function. The gene is expressed predominantly in microglia, the resident immune cells of the brain, positioning it at the intersection of neuroinflammation and neurodegeneration. [@juric2019]

The discovery of MS4A4A as an AD risk gene came from large-scale GWAS meta-analyses that identified the MS4A gene cluster on chromosome 11q12 as a significant susceptibility locus. Subsequent functional studies have revealed that MS4A4A interacts with TREM2, another critical AD risk gene, forming a functional receptor complex that regulates microglial function and amyloid clearance. [@chen2020]

Gene Information

Gene Structure and Expression

Genomic Organization

The MS4A4A gene is located at 11q12.2 within the MS4A gene cluster, a genomic region conserved across mammals. The gene spans approximately 22 kb and consists of:

• Exon count: 6 exons
• Protein length: 199 amino acids
• Molecular weight: ~22 kDa

Expression Pattern

MS4A4A shows a distinctive expression pattern:

• High expression: [Microglia](/cell-types/microglia), monocytes, macrophages, dendritic cells
• Moderate expression: B cells, natural killer cells
• Low/absent expression: [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), oligodendrocytes
• Cellular localization: Expressed on immune cell membranes, particularly in lipid raft microdomains

Regulation

MS4A4A expression is regulated by:

Protein Structure and Function

Structural Features

MS4A4A has a distinctive tetraspanin-like structure:

Tetraspanin Superfamily

MS4A4A belongs to the tetraspanin superfamily, characterized by:

• Four transmembrane helices
• Conserved CCG motif in the large extracellular loop
• Palmitoylation sites for membrane anchoring

Cellular Functions

Calcium Signaling

• Modulates calcium signaling in immune cells
• Regulates intracellular calcium concentrations
• Affects microglial activation states and phagocytic activity

Immune Regulation

• Controls microglial inflammatory responses
• May function as scavenger receptor
• Involved in immune cell differentiation
• Regulates phagocytosis of cellular debris and amyloid

TREM2 Interaction

MS4A4A forms a functional receptor complex with TREM2:

• Direct protein-protein interaction
• Co-localization on microglial surface
• Cooperative signaling in phagocytosis
• Regulation of microglial survival pathways [@berger2019]

Disease Associations

Alzheimer's Disease

MS4A4A is one of the most significant AD risk genes identified by GWAS. The gene cluster containing MS4A4A shows strong association with late-onset Alzheimer's disease (LOAD).

Genetic Variants

Mechanisms

Clinical Associations

• Cognitive decline: MS4A4A variants associated with rate of cognitive progression [@proitsi2015]
• Brain atrophy: Specific variants correlate with hippocampal and cortical atrophy [@farfel2016]
• CSF biomarkers: Genetic variants affect CSF Aβ and tau levels [@chen2021]

Multiple Sclerosis

• MS4A4A variants associated with MS susceptibility
• Alters microglial activation in lesions
• Potential therapeutic target in autoimmune demyelination

Autoimmune Disorders

• Some association with autoimmune conditions including systemic lupus erythematosus
• Role in immune regulation across multiple organ systems

Cancer

• Altered expression in some malignancies
• Potential prognostic value in certain cancers
• May affect tumor microenvironment

Molecular Mechanisms

TREM2-MS4A4A Interaction

The interaction between TREM2 and MS4A4A represents a critical mechanism in AD pathogenesis:

Microglial Activation

MS4A4A modulates microglial activation:

• DAM marker: MS4A4A+ microglia represent a disease-associated state
• Metabolic function: Regulates microglial lipid metabolism [@liu2020]
• Synaptic pruning: Involved in developmental and disease-related pruning [@martinez2019]

Lipid Metabolism

MS4A4A plays a role in microglial lipid metabolism:

• Cholesterol efflux regulation
• Lipid droplet formation
• Myelin debris processing
• Foam cell transformation

Therapeutic Implications

Drug Development

Multiple therapeutic strategies target MS4A4A:

Research Directions

• Develop MS4A4A-targeted therapeutics
• Study protective variant mechanisms
• Explore gene therapy approaches
• Biomarker development for patient stratification

Clinical Trials

• No current trials targeting MS4A4A specifically
• Broader TREM2-targeting approaches in development
• Potential combination therapies with anti-amyloid antibodies [@schwartzentruber2021]

Animal Models

Mouse Models

• Ms4a4a expression in murine microglia: Conserved expression pattern
• Knockout models: Show altered immunity and behavior
• Amyloid model crosses: Ms4a4a variants affect pathology

In Vitro Models

• Human iPSC-derived microglia: Model MS4A4A function
• MS4A4A overexpression/knockdown: Functional studies
• Organoid systems: Three-dimensional brain models

Genetic Studies

GWAS Findings

The MS4A gene cluster was first identified as an AD risk locus in 2011 and has been validated in multiple subsequent meta-analyses:

• Chromosome 11q12: Contains MS4A4A, MS4A6A, MS4A7, and other family members
• Genome-wide significance: Multiple independent signals in the locus
• Population-specific effects: Some variants show ancestry-specific effects

Functional Genomics

• eQTL analysis: Risk variants affect MS4A4A expression in brain tissue
• Methylation studies: Epigenetic changes correlate with genetic risk
• Transcriptomic analysis: MS4A4A expression increases in AD microglia

Interaction Network

Protein Interactions

Signaling Pathways

• PI3K/Akt pathway: Cell survival and metabolic regulation
• MAPK pathway: Inflammatory signaling
• Calcium signaling: Cellular activation states

Cross-Linking

MS4A4A connects to multiple disease pathways:

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [TREM2 Gene](/genes/trem2)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [MS4A Gene Family](/genes/ms4a-gene-family)
• [Phagocytosis](/mechanisms/phagocytosis)
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Lipid Metabolism](/mechanisms/lipid-metabolism)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)

References

Allen Brain Atlas Data

Gene Expression

• Cerebral cortex - Microglia and astrocytes
• Hippocampus - Microglial expression
• White matter - Myelinating cells
• Cerebellum - Low expression

Brain Region Expression Levels

Single-Cell Expression

• Microglia (highest)
• Some astrocytes

External Resources

• [Allen Brain Atlas - MS4A4A Expression](https://portal.brain-map.org/)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/explore/classes/nucleus)

External Links

MS4A4A encodes a tetraspanin-like membrane protein with characteristic features:

Primary Structure:

• Protein length: 199 amino acids
• Molecular weight: ~22 kDa
• Isoelectric point: 5.8
• Post-translational modifications: N-glycosylation sites

• Four transmembrane domains: Characteristic of MS4A family proteins
• N-terminal extracellular domain: Contains ligand-binding regions
• C-terminal intracellular tail: Contains signaling motifs
• Conserved cysteine residues: Form intramolecular disulfide bonds

• Tetraspanin superfamily organization
• Palmitoylation sites for membrane anchoring
• Potential lipid raft association
• Dimerization capability

Isoforms and Variants

Multiple MS4A4A isoforms exist with tissue-specific expression:

Isoforms:

• Full-length isoform: 199 amino acids (canonical)
• Alternative splice variants: Truncated forms with modified function
• Soluble form: May be generated through proteolytic cleavage

• rs15805: Primary AD-associated variant (protective T allele)
• rs6102059: Risk variant affecting expression
• rs4939883: Linked to lipid metabolism

Expression Patterns

Tissue Distribution

MS4A4A exhibits highly specific expression patterns:

Immune Cells:

• Microglia: Highest expression in brain-resident macrophages
• Monocytes: High expression, downregulates upon differentiation
• Macrophages: Moderate expression
• Dendritic cells: Low to moderate expression
• B cells: Low expression

• Primary expression on microglia (CD11b+ cells)
• Very low or absent on neurons
• Very low or absent on astrocytes
• Expression increases with age and in AD brain

• Limited expression in non-immune tissues
• Detectable in spleen and lymph nodes

Regulation

MS4A4A expression is dynamically regulated:

Transcriptional Regulation:

• Promoter contains NF-κB binding sites
• IFN-γ induces expression
• TGF-β modulates levels
• PPARγ agonists reduce expression

• miRNA targeting (miR-155, miR-124)
• Alternative splicing regulation
• RNA-binding protein control

• Increased expression in AD brain
• Expression correlates with plaque burden
• TREM2 expression linked to MS4A4A levels

Cellular Functions

Calcium Signaling

MS4A4A plays a role in calcium homeostasis:

Mechanism:

• Forms calcium-permeable channels
• Regulates intracellular calcium concentrations
• Modulates store-operated calcium entry
• Affects calcium-dependent signaling cascades

• Alters microglial activation thresholds
• Affects phagocytic capacity
• Modulates cytokine release
• Influences cell survival

Immune Regulation

MS4A4A modulates immune cell functions:

Phagocytosis:

• Regulates microglial phagocytosis of debris
• Affects amyloid clearance capacity
• Modulates complement-mediated uptake
• Controls Fc receptor function

• Modulates pro-inflammatory cytokine release
• Affects anti-inflammatory mediator production
• Alters chemokine secretion
• Influences inflammasome activation

• Controls microglial morphological changes
• Affects proliferation capacity
• Modulates antigen presentation
• Regulates cell migration

TREM2 Interaction

A critical functional relationship exists between MS4A4A and TREM2:

Interaction Mechanism:

• Physical association on microglial membrane
• Coordinated signaling downstream
• Shared downstream pathways
• Genetic epistasis

• Combined effects on phagocytosis
• Synergistic regulation of inflammation
• Coordinated metabolic regulation
• Enhanced cellular responses

• Combined targeting potential
• Biomarker development
• Precision medicine applications

Role in Alzheimer's Disease

Genetic Association

MS4A4A was identified as an AD risk gene through large-scale GWAS:

GWAS Findings:

• Discovery: Multiple independent signals in MS4A gene cluster
• Primary variant: rs15805 (T allele protective)
• Effect size: Odds ratio ~0.85-0.90 for protective allele
• Population: Replicated in European, Asian, and African cohorts

• Altered gene expression levels
• Modified protein function
• Splicing pattern changes
• Regulatory effects

Pathogenic Mechanisms

1. Dysregulated Microglial Activation

MS4A4A variants alter microglial phenotypes:

Mechanism:

• Changes in calcium signaling affect activation states
• Modified response to amyloid
• Altered morphological transformation
• Dysregulated inflammatory responses

• Expression correlates with disease severity
• Variant carriers show distinct microglial phenotypes
• Mouse models confirm role

2. Impaired Amyloid Clearance

MS4A4A affects microglial phagocytosis:

Mechanism:

• Calcium-dependent phagocytic capacity
• TREM2协同效应
• Complement involvement
• Cell autonomous effects

• Protective variants enhance clearance
• Knockout mice show accumulation
• Human studies correlate expression with burden

3. Neuroinflammation Modulation

MS4A4A variants influence inflammatory responses:

Mechanism:

• Altered cytokine production profiles
• Modified chemokine secretion
• Changed inflammasome activation
• Modified cell-cell communication

• Chronic neuroinflammation
• Amplified neuronal damage
• Progressive pathology

4. Tau Pathology Interaction

Emerging evidence links MS4A4A to tau:

Mechanism:

• Microglial-mediated tau spreading
• Inflammation-dependent tau modification
• Clearance pathway involvement

• Expression correlates with tau burden
• Genetic variants associated with tauopathy
• Mouse models show effects

Interaction with Other AD Risk Genes

MS4A4A operates within a network:

Therapeutic Implications

Targeting MS4A4A

MS4A4A represents a promising therapeutic target:

Approaches:

• Monoclonal antibodies: Enhance or block function
• Small molecules: Modulate channel activity
• Gene therapy: Deliver protective variants
• RNA-based: ASOs or siRNA targeting

• Brain delivery
• Target specificity
• Functional complexity
• Peripheral effects

Combination Therapy

MS4A4A is an excellent candidate for combination approaches:

With TREM2 Modulators:

• Synergistic enhancement of phagocytosis
• Combined anti-inflammatory effects
• Rationale for dual targeting

• CD33 inhibitors
• Complement inhibitors
• Anti-inflammatory agents

Biomarker Applications

MS4A4A has several biomarker uses:

Genetic Biomarkers:

• rs15805 genotype for risk stratification
• Haplotype analysis
• Polygenic risk scores

• Peripheral blood monocyte expression
• CSF levels (under investigation)
• PET ligands in development

Research Directions

Outstanding Questions

Key questions remain:

Emerging Research

New approaches include:

• Single-cell analysis of MS4A4A+ microglia
• Structural studies of MS4A4A-TREM2 complex
• Human iPSC-derived microglia models
• Novel therapeutic modalities

Animal Models

Mouse Models

Ms4a4a Knockout:

• Viable with minor phenotypes
• Altered microglial function
• Enhanced inflammatory responses

• Human MS4A4A expression in mouse microglia
• Modified amyloid response
• Validates therapeutic targeting

• Accelerated pathology with overexpression
• Protected phenotype with knockout
• Confirms role in clearance

Model Considerations

• Species differences in MS4A family
• Mouse/human expression pattern differences
• Need for humanized models

Clinical Relevance

Genetic Testing

Current Status:

• Included in some AD risk panels
• Utility in polygenic risk scores
• Not for standalone predictive testing

• Risk stratification
• Prevention planning
• Clinical trial enrichment

Patient Stratification

Applications:

• Genotype-guided therapy selection
• Biomarker development
• Precision medicine approaches

Comparative Biology

MS4A Gene Family

The MS4A family contains multiple genes:

Evolutionary Conservation

• MS4A4A conserved in mammals
• Orthologs in rodent species
• Essential for microglial function
• Positive selection in human lineage

Future Directions

Therapeutic Development

Priority areas include:

• Antibody development for brain delivery
• Small molecule modulators
• Gene therapy approaches
• Biomarker validation

Basic Research

Remaining questions:

• Structural mechanism of function
• Cell-type specific effects
• Temporal dynamics in disease
• Interaction with other risk genes

References

External Links

• [NCBI Gene: MS4A4A](https://www.ncbi.nlm.nih.gov/gene/246213)
• [Ensembl: ENSG00000166926](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166926)
• [UniProt: Q9H3Y1](https://www.uniprot.org/uniprot/Q9H3Y1)
• [GeneCards: MS4A4A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MS4A4A)
• [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000166926-MS4A4A)

Pathway Diagram

See Also

Related Hypotheses:

• [Lysosomal Membrane Repair Enhancement](/hypotheses/h-8986b8af)
• [Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Therapy](/hypotheses/h-ac55ff26)
• [Membrane Cholesterol Gradient Modulators](/hypotheses/h-9d29bfe5)
• [CYP46A1 Overexpression Gene Therapy](/hypotheses/h-2600483e)
• [TREM2 Conformational Stabilizers for Synaptic Discrimination](/hypotheses/h-044ee057)

• [kg-expand-GENES](/analysis/kg-expand-GENES)
• [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01)
• [Autophagy-lysosome pathway convergence across neurodegenerative diseases](/analysis/SDA-2026-04-01-gap-011)

• [Macroautophagy Dysfunction in PD - Experiment Design](/experiment/exp-wiki-experiments-macroautophagy-dysfunction-parkinsons)

Pathway Diagram

The following diagram shows the key molecular relationships involving MS4A4A Gene — Membrane-Spanning 4-Domains A4A discovered through SciDEX knowledge graph analysis: